Drug intelligence / Profile preview

oxetacaine + aluminium hydroxide + magnesium hydroxide

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Oxetacaine + aluminium hydroxide + magnesium hydroxide is an oral pharmaceutical combination used primarily to treat symptoms of hyperacidity, heartburn, indigestion, gastritis, peptic ulcers, and gastroesophageal reflux disease (GERD). Aluminium hydroxide and magnesium hydroxide are antacids that neutralize excess gastric acid in the stomach. Oxetacaine is a local anesthetic that provides pain relief by numbing the gastric mucosa. This combination offers both rapid acid neutralization and symptomatic relief from pain or discomfort associated with acidic injury or ulcers. The product is available as suspensions or gels under various brand names[1][5][6][8].

Brand names
3-Gel7-LA
Other names
aluminium hydroxide + magnesium hydroxide + oxetacainealuminum hydroxide + magnesium hydroxide + oxetacaine
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on oxetacaine + aluminium hydroxide + magnesium hydroxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxetacaine + aluminium hydroxide + magnesium hydroxide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call